The study found that Medicare Part D’s share of annual spending on ultra-expensive drugs increased by 1,170 percent between 2012 and 2018, largely because more beneficiaries were prescribed such drugs during this time period.
The researchers said their findings underscore a national conversation about ultra-expensive drug’s sustainability and affordability.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.